Funding news · Sep 8, 2026
GenHealth.ai Closes $16.5M Series A Led by Flare Capital Partners
GenHealth.ai Raises $16.5M Series A
GenHealth.ai, a developer of AI agents for healthcare back-office and revenue-cycle work, has raised $16.5 million in Series A funding. The round was led by Flare Capital Partners and included participation from ARTIS Ventures, Epsilon Health Investors, Obvious Ventures, Craft Ventures, Eniac Ventures, and InHealth Ventures. The funding date is September 8, 2026.
What GenHealth.ai Does
GenHealth.ai builds AI agents that run healthcare back-office and revenue-cycle work end to end inside the EHRs, payer portals, fax and phone systems providers already use. The agents handle patient intake, eligibility verification, prior authorization, billing and denials. The company runs its agents on a proprietary Large Medical Model trained on the coded claims and clinical histories of more than 140 million patients.
Founded in 2023 by Ricky Sahu (CEO) and Ethan Siegel (CPO) out of health-data interoperability startup 1upHealth, GenHealth.ai is headquartered in Boston. It serves medical groups, durable medical equipment suppliers and health plans, with US-based billers and customer staff handling exceptions.
Why This Matters for Acquirers
Revenue-cycle management is a pain point for healthcare providers, with administrative costs consuming a significant portion of spending. GenHealth.ai's AI agents automate manual, error-prone processes, potentially reducing denials and accelerating reimbursements. The company's proprietary Large Medical Model, trained on a vast dataset of claims and clinical histories, creates a defensible data advantage.
For potential acquirers, GenHealth.ai offers a scalable solution that integrates with existing healthcare IT infrastructure. The Series A funding will likely support expansion of the agent capabilities, customer base, and data assets. The involvement of healthcare-focused investors like Flare Capital Partners and ARTIS Ventures underscores confidence in the company's approach.
Funding Details
- Round: Series A
- Amount: $16,500,000 USD
- Date: September 8, 2026
- Lead Investor: Flare Capital Partners
- Participating Investors: ARTIS Ventures, Epsilon Health Investors, Obvious Ventures, Craft Ventures, Eniac Ventures, InHealth Ventures
About GenHealth.ai
GenHealth.ai builds AI agents that run healthcare back-office and revenue-cycle work — patient intake, eligibility verification, prior authorization, billing and denials — end to end inside the EHRs, payer portals, fax and phone systems providers already use. Founded in 2023 by Ricky Sahu (CEO) and Ethan Siegel (CPO) out of health-data interoperability startup 1upHealth, the company runs its agents on a proprietary Large Medical Model trained on the coded claims and clinical histories of more than 140 million patients. Headquartered in Boston, it serves medical groups, durable equipment suppliers and health plans, with US-based billers and customer staff handling exceptions.
Acquisition Angle
GenHealth.ai's focus on automating revenue-cycle operations positions it as a strategic asset for healthcare IT vendors, payer organizations, or revenue-cycle management companies seeking to enhance their AI capabilities. The proprietary Large Medical Model and existing integrations with EHRs and payer portals create barriers to entry. The Series A round provides capital to scale operations and further develop the technology, making GenHealth.ai a compelling acquisition target in the healthcare AI space.